Important Note
No screen can guarantee “fast profit” in 1–2 days. What these filters do is tilt the odds a bit in your favor by focusing on stocks that are liquid, showing short‑term strength, and statistically modeled to have a higher probability of a near‑term rise—especially within TVTX’s sector.
Screening Filters
monthly_average_dollar_volume ≥ 200,000
- Purpose: Ensure sufficient liquidity for short‑term trading.
- Rationale:
- For a 1–2 day trade, you must be able to get in and out without moving the price too much.
- A minimum monthly average dollar volume of $200k (price × volume) filters out thinly traded names where spreads are wide and slippage can destroy a “fast profit” idea.
moving_average_relationship: PriceAboveMA5
- Purpose: Capture stocks in a short‑term uptrend.
- Rationale:
- MA5 is a very short moving average (roughly the last week of trading days).
- Price above the 5‑day MA means the stock is currently trading stronger than its recent average—classic short‑term momentum.
- If you want potential gains over a day or two, buying into names already in a near‑term upswing is more aligned with that goal than buying laggards.
sector: Healthcare, Pharmaceuticals & Medical Research
- Purpose: Focus on the same broad sector as TVTX.
- Rationale:
- TVTX is in healthcare/biotech; this sector tends to be catalyst‑driven (FDA decisions, trial data, approvals—like the Filspari approval mentioned for TVTX) and often moves sharply in short windows.
- Limiting to this sector finds peers operating in similar regulatory and news environments, where short bursts of volatility—and thus short‑term trading opportunities—are more common.
industry: Biotechnology & Medical Research, Pharmaceuticals
- Purpose: Narrow further to TVTX‑like business models.
- Rationale:
- Biotech and pharma names often trade on binary or semi‑binary events (trial readouts, approvals, label expansions), which can cause 1–3 day surges.
- Focusing on these industries keeps the universe aligned with stocks that, like TVTX, can make large short‑term moves, which is what you’re targeting.
one_day_rise_prob ≥ 55
- Purpose: Require a statistically higher‑than‑random probability of a 1‑day gain.
- Rationale:
- This is typically model‑driven: based on historical patterns, volatility, momentum, order flow, etc., the system estimates the probability the stock closes higher the next day.
- A minimum of 55% means you’re only looking at names where the model gives you at least a modest edge over a 50/50 coin flip for tomorrow’s direction—important for a 1–2 day “fast profit” attempt.
one_day_predict_return: min 2%, max 20%
- Purpose: Filter for meaningful but not extreme expected 1‑day returns.
- Rationale:
- Min 2%: Ensures the modeled next‑day upside is big enough to matter for a quick trade; a 0.5–1% move is often not worth the risk and transaction costs.
- Max 20%: Excludes extreme outliers where the model projects very high moves, which are often based on rare or highly speculative situations (e.g., microcaps around binary events) and can be more like gambling than trading.
- This range balances “enough upside to chase” with “not purely lottery‑ticket behavior.”
Why Results Match Your Intent
You’re asking about fast profit over 1–2 days, and these filters collectively:
- Focus on liquid names (easier to enter/exit quickly).
- Require short‑term positive momentum (price above MA5).
- Restrict to biotech/pharma, the same space as TVTX, where short‑term spikes around news are common.
- Add quantitative edges: a higher modeled probability of a 1‑day rise and a meaningful but not extreme expected 1‑day return.
In other words, the screener is not saying “these will definitely make you money tomorrow,” but it is selecting stocks that, like TVTX after its FDA catalyst, are:
- Actively traded,
- In sectors that can move quickly,
- Currently showing strength,
- And statistically tilted toward a short‑term upside move.
This list is generated based on data from one or more third party data providers. It is provided for informational purposes only by Intellectia.AI, and is not investment advice or a recommendation. Intellectia does not make any warranty or guarantee relating to the accuracy, timeliness or completeness of any third-party information, and the provision of this information does not constitute a recommendation.